Clinical Trials Browser

Phase 1/2 × Thyroid Neoplasms × Thyrotropin Alfa × Clear all

NCT03276988 2020-09-09

Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients

Phase 1/2 Completed

Thyroid Neoplasms